These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12516686)

  • 1. Tissue factor and thrombomodulin in hemodialysis patients: associations with endothelial injury, liver disease, and erythropoietin therapy.
    Borawski J; Naumnik B; Mysliwiec M
    Clin Appl Thromb Hemost; 2002 Oct; 8(4):359-67. PubMed ID: 12516686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hemodialysis on plasma levels of vascular endothelial markers.
    Naumnik B; Borawski J; Pawlak K; Myśliwiec M
    Clin Appl Thromb Hemost; 2002 Jul; 8(3):245-50. PubMed ID: 12361202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response.
    Borawski J; Naumnik B; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2001 Jul; 16(7):1442-7. PubMed ID: 11427638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory markers and platelet aggregation tests as predictors of hemoglobin and endogenous erythropoietin levels in hemodialysis patients.
    Borawski J; Pawlak K; Myśliwiec M
    Nephron; 2002 Aug; 91(4):671-81. PubMed ID: 12138272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis.
    Inoue A; Wada H; Takagi M; Yamamuro M; Mukai K; Nakasaki T; Shimura M; Hiyoyama K; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Shiku H
    Clin Appl Thromb Hemost; 2000 Apr; 6(2):100-3. PubMed ID: 10775031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum hepatocyte growth factor is associated with viral hepatitis, cardiovascular disease, erythropoietin treatment, and type of heparin in haemodialysis patients.
    Borawski J; Myśliwiec M
    Nephrol Dial Transplant; 2002 Apr; 17(4):637-44. PubMed ID: 11917058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease.
    Tacke F; Schöffski P; Trautwein C; Manns MP; Ganser A; von Depka M
    Blood Coagul Fibrinolysis; 2001 Oct; 12(7):539-45. PubMed ID: 11685041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapy.
    Tomura S; Nakamura Y; Deguchi F; Chida Y; Ohno Y; Kodama S; Hayashi T; Suzuki K; Marumo F
    Thromb Res; 1990 May; 58(4):413-9. PubMed ID: 2162087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis.
    Takagi M; Wada H; Mukai K; Kihira H; Yano S; Minamikawa K; Wakita Y; Nakase T; Nagaya S; Deguchi K
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):713-7. PubMed ID: 7865676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of the three endothelial-specific proteins von Willebrand factor, tissue factor pathway inhibitor, and thrombomodulin do not predict the development of acute respiratory distress syndrome.
    Bajaj MS; Tricomi SM
    Intensive Care Med; 1999 Nov; 25(11):1259-66. PubMed ID: 10654210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of serotonergic mechanisms in the thrombotic complications in hemodialyzed patients treated with erythropoietin.
    Małyszko JS; Małyszko J; Pawlak K; Pawlak D; Buczko W; Myśliwiec M
    Nephron; 2000 Apr; 84(4):305-11. PubMed ID: 10754406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant erythropoietin therapy on circulating endothelial markers in hemodialysis patients.
    Borawski J; Myśliwiec M
    Clin Appl Thromb Hemost; 2002 Jan; 8(1):77-84. PubMed ID: 11991244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble thrombomodulin is associated with viral hepatitis, blood pressure, and medications in haemodialysis patients.
    Borawski J; Naumnik B; Pawlak K; Myśliwiec M
    Nephrol Dial Transplant; 2001 Apr; 16(4):787-92. PubMed ID: 11274275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy.
    Fujiwara Y; Tagami S; Kawakami Y
    J Atheroscler Thromb; 1998; 5(1):21-8. PubMed ID: 10077454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure].
    Pawlak K; Pawlak D; Myśliwiec M
    Pol Arch Med Wewn; 2005 Jan; 113(1):21-6. PubMed ID: 16130597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
    Makin AJ; Blann AD; Chung NA; Silverman SH; Lip GY
    Eur Heart J; 2004 Mar; 25(5):371-6. PubMed ID: 15033248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress - a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients.
    Pawlak K; Naumnik B; Brzósko S; Pawlak D; Myśliwiec M
    Am J Nephrol; 2004; 24(1):154-61. PubMed ID: 14726627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant human erythropoietin on functional and injury endothelial markers in peritoneal dialysis patients.
    Aguilera A; Selgas R; Ruiz-Caravaca ML; Bajo MA; Cuesta MV; Plaza MA; Hernanz A
    Perit Dial Int; 1999; 19 Suppl 2():S161-6. PubMed ID: 10406511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.